EXHI Stock Overview
Exlites Holdings International, Inc. manufactures and distributes medical products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Exlites Holdings International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.28 |
| 52 Week High | US$3.00 |
| 52 Week Low | US$0.018 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -84.28% |
| 5 Year Change | 183.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EXHI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 6.5% | -3.2% |
| 1Y | n/a | 4.0% | 19.3% |
Return vs Industry: Insufficient data to determine how EXHI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how EXHI performed against the US Market.
Price Volatility
| EXHI volatility | |
|---|---|
| EXHI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EXHI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine EXHI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Mark Julian | exlitesholdings.us |
Exlites Holdings International, Inc. manufactures and distributes medical products. The company distributes and manufactures therapeutic pain, exercise, weight loss, and DVT prevention systems for use by patients. It sells proprietary patented and patent pending health care products, such as deep vein thrombosis units, transcutaneous electrical nerve stimulation units, electronic muscle stimulation units, various bracing products, and other medical and consumer healthcare products.
Exlites Holdings International, Inc. Fundamentals Summary
| EXHI fundamental statistics | |
|---|---|
| Market cap | US$12.46m |
| Earnings (TTM) | US$6.86k |
| Revenue (TTM) | US$9.42m |
0.0x
P/E Ratio0.0x
P/S RatioIs EXHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXHI income statement (TTM) | |
|---|---|
| Revenue | US$9.42m |
| Cost of Revenue | US$8.59m |
| Gross Profit | US$829.17k |
| Other Expenses | US$822.32k |
| Earnings | US$6.86k |
Last Reported Earnings
Jan 31, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EXHI perform over the long term?
See historical performance and comparison